HIGHLIGHTS
- who: CASE REPORT and colleagues from the Japan, Department of Radiology, Tokai University Hachioji Hospital, Tokai University School of Medicine have published the Article: Oxford Medical Case Reports, 2021;7,263-265, in the Journal: (JOURNAL)
- what: The authors report a case where tumor regression of diaphragmatic metastasis following EGFR-TKI therapy caused perforation leading to a diaphragmatic hernia (DH).
SUMMARY
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are first-line therapy for patients with nonsmallcell lung cancer (NSCLC) harboring EGFR mutations. Compared with platinum-based chemotherapy, EGFR-TKIs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.